Discover who we are and our partners global network, as well as learn more about our people.

Learn more about our products and how they provide innovative solutions for patiens' unmet needs.

Discover our capabilities in project design services.

Find information such as website news, press releases and event presentations.

Get in touch with us to set up a meeting or propose your cooperation.

WHAT WE DO

Providing Value for Patients Suffering from Rare Diseases

As a Swiss based healthcare company with a global reach, we identify, develop and commercialize science driven branded products on a global basis, which can provide significant benefits over existing options in the treatment of niche and rare diseases through improved efficacy, safety or patient convenience.

We build value thanks to our outstanding ability to combine drug development expertise with proprietary drug delivery technologies to deliver to patients suffering from rare diseases with solution meaningfully improving their life and empowering caregivers with better tools to manage such rare diseases.

Prescription Products

We are committed to delivering innovation in treating rare and orphan diseases as the result of a validated process divided in three steps:

identify

develop

market

OUR STRATEGIC APPROACH

The cornerstones of our strategy are the following:

Innovation: Starting from a deep understanding of the patient journey, we identify still unmet medical needs in specialized therapeutic areas or the rare/orphan diseases field to be addressed through drug repurposing or the application of novel drug delivery technologies (preferably platform technologies protected by international patents), which are potentially applicable to several drug candidates in different therapeutic areas.

Development: Products are internally developed and financed (independently or with our co-development partners who are able to provide complementary know-how and competencies) by directly managing and controlling the key steps of the process - from proprietary technologies applications and/or novel dosage forms finalization to pre-clinical and clinical activities, market authorization and regulatory approval obtainment. In case of need, we enter into strategic outsourcing relationships to complete the development as well as to manufacture our product candidates in a cost-effective manner.

Partnering: We rely on solid companies for distribution, promotion, marketing and commercialization of our products on a worldwide basis.

Marketing: We promote and market selected products of our range in rare/orphan diseases with our own sales force and infrastructure in selected strategically significant countries.

Service: We support third party projects by offering pharma companies high-value contract development services based on advanced patented technologies, know-how and world-class pharma development expertise.

identify

develop

market

identify

Unmet healthcare needs.
Product/technology to meet these needs, cost effectively.

APR Products

develop

Market strategy and target product profile.
Marketing plan identifying activities and resources needed.
Execute plan timely and cost efficiently

Our Services

Collaboration & Partnering

market

Create and nurture a global partner network with top pharma companies in target countries
Set up a own sales and marketing organization in selected countries
Provide valuable services to partners on an ongoing basis

Collaboration & Partnering

OUR CORE COMPETENCIES

We employ a project management approach that allows us to synchronize and manage all phases of product development in order to minimize time, risks and reduce costs.

APR focuses on scientifically driven risk/benefit analysis combined with patient/consumer need evaluation process and integrating product characteristics with regulatory and investment information.

As healthcare company, we focus on a scientifically driven risk/benefit analysis combined with a patient/consumer need evaluation process and on integrating product characteristics with regulatory and investment information.

We work closely with authorities in Europe and the USA to provide the optimal strategy for regulatory approval, in order to be able to quickly distribute the products in as many geographies as possible.

We are able to develop the optimal formulation and its related delivery format which best addresses the identified need; We also employ specialists with an in-depth knowledge of a given healthcare product's physical and chemical characteristics - fundamental in determining optimal formulations and dosing characteristics to meet our clients' and patients'/consumers' needs.

We take an integrated multi-phase approach on pre-formulation development, compatibility tests, prototype development, stability studies, scaling-up and validation to clinical trials and registration.